Showing results (1781-1790 of 2,612) with videos related to

Sort By:
Pageof 262
Cancer Biotherapy & Radiopharmaceuticals|December 30, 2008
Comparative dosimetric evaluation of nanotargeted (188)Re-(DXR)-liposome for internal radiotherapyChih-Hsien Chang, Michael G Stabin, Ya-Jen Chang, et al.
Translational Andrology and Urology|April 14, 2021
TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?-a narrative reviewAlessandro Rizzo, Veronica Mollica, Alessia Cimadamore, et al.
Nuclear Medicine and Biology|February 4, 2010
Therapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumor modelYa-Jen Chang, Chih-Hsien Chang, Chia-Yu Yu, et al.
Nucleic Acids Research|April 29, 2025
OntoTiger: a platform of ontology-based application tools for integrative biomedical explorationHaixiu Yang, Guoyou He, Meiyi Zhang, et al.
Future Oncology (London, England)|April 6, 2011
The landscape of EGFR pathways and personalized management of non-small-cell lung cancerLiang Cheng, Shaobo Zhang, Riley Alexander, et al.
Science China. Life Sciences|January 26, 2026
Cell type-specific contribution of low-density lipoprotein receptor to atherosclerosisWei-Hui Li, Yu-Liang Zhang, Ya-Fen Zhang, et al.
International Journal of Molecular Sciences|January 17, 2013
Depigmentation effect of kadsuralignan F on melan-a murine melanocytes and human skin equivalentsMyeong-Jin Goh, Hae-Kwang Lee, Liang Cheng, et al.
Cancer|July 19, 2002
Fas and Fas ligand expression is elevated in prostatic intraepithelial neoplasia and prostatic adenocarcinomaJiazhong Jiang, Thomas M Ulbright, Shaobo Zhang, et al.
Human Pathology|June 13, 2008
Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumorsLin Li, Haodong Xu, Betsy O Spaulding, et al.
Pageof 262